Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery
NCT00777842 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2015-12-31
Summary
The GTX™ Drug Eluting Coronary Stent System is intended for the treatment of patients with a lesion in the coronary artery.
Conditions
Interventions
- DEVICE
-
GTX™ Drug Eluting Coronary Stent System
Drug eluting stent
Sponsors & Collaborators
-
Cook Group Incorporated
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- Germany
Study Locations
More Related Trials
-
A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.
NCT00597142 ·Status: COMPLETED ·Phase: PHASE4
-
The Asahi Intecc PTCA Chronic Total Occlusion Study
NCT02379923 ·Status: COMPLETED ·Phase: NA
-
Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)
NCT01177592 ·Status: TERMINATED ·Phase: NA
-
RESOLUTE ONYX Post-Approval Study
NCT03063749 ·Status: COMPLETED
-
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
NCT06094127 ·Status: ACTIVE_NOT_RECRUITING
-
the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration
NCT05126446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms
NCT00816062 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection
NCT05430672 ·Status: UNKNOWN ·Phase: NA
-
Enable I Long-term Follow-up Study
NCT01636648 ·Status: TERMINATED
-
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
NCT03322033 ·Status: TERMINATED ·Phase: NA
-
Thoracoabdominal Artery Stent Graft System Exploratory Study
NCT06710938 ·Status: RECRUITING ·Phase: NA
-
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
NCT06827990 ·Status: RECRUITING ·Phase: NA
-
Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
NCT00805948 ·Status: TERMINATED ·Phase: NA
-
Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection
NCT03033043 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation
NCT00422435 ·Status: COMPLETED ·Phase: PHASE3
-
A European Study on Medical Management Versus TAG Device + Medical Management for Acute Uncomplicated Type B Dissection
NCT00742274 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of the transShield Embolic Protection System
NCT06652841 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
NCT02777593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Talent Aortic Cuff Stent Graft System Compassionate Use Registry
NCT00604643 ·Status: NO_LONGER_AVAILABLE
-
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
NCT00608829 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
NCT03090230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
NCT00590759 ·Status: COMPLETED ·Phase: NA
-
Thoracic Endoprosthesis for Treatment of Aneurysm of the Descending Thoracic Aortic
NCT00874250 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
NCT00287573 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
NCT05639569 ·Status: RECRUITING